This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
doi: 10.1371/journal.pone.0051620. Epub 2012 Dec 13.

Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation

Affiliations

Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation

Henry Tumwebaze et al. PLoS One. 2012.

Abstract

Background: Combination HIV prevention initiatives incorporate evidence-based, biomedical and behavioral interventions appropriate and acceptable to specific populations, aiming to significantly reduce population-level HIV incidence. Knowledge of HIV serostatus is key to linkages to HIV care and prevention. Household-based HIV counseling and testing (HBCT) can achieve high HIV testing rates. We evaluated HBCT as a platform for delivery of combination HIV prevention services in sub-Saharan Africa.

Methods: We conducted HBCT in a semi-urban area in southwestern Uganda. All adults received standard HIV prevention messaging. Real-time electronic data collection included a brief risk assessment and prevention triage algorithm for referrals of HIV seropositive persons to HIV care and uncircumcised HIV seronegative men with multiple sex partners to male circumcision. Monthly follow-up visits for 3 months were conducted to promote uptake of HIV care and male circumcision.

Results: 855 households received HBCT; 1587 of 1941 (81.8%) adults were present at the HBCT visit, 1557 (98.1% of those present) were tested and received HIV results, of whom, 46.5% were men. A total of 152 (9.8%) were HIV seropositive, for whom the median CD4 count was 456 cells/μL, and 50.7% were newly-identified as HIV seropositive. Three months after HBCT, 88.5% of HIV seropositive persons had attended an HIV care clinic; among those with CD4 counts <250 cells/μL, 71.4% initiated antiretroviral therapy. Among 123 HIV seronegative men with an HIV+ partner or multiple partners, 62.0% were circumcised by month 3.

Conclusions: HBCT achieves high levels of knowledge of HIV serostatus and is an effective platform for identifying at-risk persons and achieving higher uptake of HIV prevention and care services through referrals and targeted follow-up than has been accomplished through other single focus strategies.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Cumulative probability of visiting an HIV clinic.
Results are overall among a) all HIV seropositive persons (n = 152) and b) those not already on ART at baseline (n = 120). After month one, for those on ART, follow-up was discontinued. The cumulative probability of visiting an HIV clinic by 3 months was 88.5% overall and 85.3% among those not already on ART at baseline (Figure 1a and 1b, respectively).
Figure 2
Figure 2. Cumulative probability of ART initiation, among HIV seropositive persons with a CD4 count <250 cells/μL and not on ART at baseline.
Results are shown for the 21 HIV seropositive individuals who had a baseline CD4 count <250 cells/μL and were eligible for ART by Ugandan guidelines but not taking 7 ART at baseline. The cumulative probability of ART initiation by 3 months among those with CD4 count <250 cells/μL and not on ART at baseline was 71.4%.
Figure 3
Figure 3. Cumulative probability of male circumcision, among HIV seronegative men with multiple partners or a known HIV seropositive partner.
Results are shown for the 123 HIV seronegative men with>1 sexual partner (>2 if polygamous) or a known HIV seropositive partner who were referred for medical male circumcision. The cumulative probability of male circumcision by 3 months was 62.0%.

References

    1. UNAIDS (2012) Global AIDS Response progress reporting: monitoring the 2011 political declaration on HIV/AIDS: guidelines on construction of core indicators: 2012 reporting. JC2215E.
    1. Gray R, Kigozi G, Serwadda D, Kong X, Nalugoda F, et al... (2012) Population-level impact of male circumcision on HIV incidence: Rakai, Uganda. 19th Conference on Retroviruses and Opportunistic Infections (CROI). Seattle, WA. pp. Abstract 36.
    1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Medicine 2: e298. - PMC - PubMed
    1. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643–656. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493–505. - PMC - PubMed

Publication types

Cite

AltStyle によって変換されたページ (->オリジナル) /